Eric A Collisson MD

Instructor, Medicine, UCSF School of Medicine

825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-520-5000

Dr. Collisson is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Collisson's full profile Already have an account?

Education & Training

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2005 - 2007
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2003 - 2005
David Geffen School of Medicine at UCLAClass of 2002

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2004 - 2028
WA State Medical License 2024 - 2027
CA State Medical License 2004 - 2026
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2015-2017

Publications & Presentations

PubMed

8 citations
AI-Driven insights in pancreatic cancer imaging: from pre-diagnostic detection to prognostication.
Ajith Antony, Sovanlal Mukherjee, Yan Bi, Eric A Collisson, Madhu Nagaraj
Abdominal Radiology. 2025-07-01
3 citations
Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning.
Gabriella O Estevam, Edmond Linossi, Jingyou Rao, Christian B Macdonald, Ashraya Ravikumar
Elife. 2025-02-17
7 citations
Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning.
Gabriella O Estevam, Edmond M Linossi, Jingyou Rao, Christian B Macdonald, Ashraya Ravikumar
Biorxiv. 2024-12-05

Journal Articles

Cell of Origin and Mutation Pattern Define Three Clinically Distinct Classes
Eric A Collisson, Raymond J Cho, Nature

Lectures

Using Molecular Diagnostics Across the Cancer Care Continuum to Enhance the
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020

Press Mentions

‘Exciting Time in Precision Medicine:’ Fred Hutch Symposium Offers National Leaders in Cancer VaccinesSeptember 27th, 2024
Is Iron the Achilles’ Heel for Cancer?April 4th, 2022
Cancer Cells Feed on Iron: Scientists Have an AdvantageApril 3rd, 2022

Grant Support

Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid BiopsyFRED HUTCHINSON CANCER CENTER2021–2027
Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid BiopsyFRED HUTCHINSON CANCER CENTER2021–2027
Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid BiopsyFRED HUTCHINSON CANCER CENTER2021–2027
Understanding efficacy and FE(II)-Promoted Activation of 1,2,4-Trioxolanes in cancerFRED HUTCHINSON CANCER CENTER2021–2026
Optimizing Treatment Approaches to Lung Cancers Harboring MET Exon 14FRED HUTCHINSON CANCER CENTER2019–2025